ERGs, cone-isolating VEPs and analytical techniques in children with cone dysfunction syndromes

Documenta Ophthalmologica

Volumn 106, Issue 3, 2003, Pages 289-304

  Kelly, John P ^a,b   Crognale, Michael A ^c   Weiss, Avery H ^a,b  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

Color vision; Electroretinography; Retinal dystrophy; Visual evoked potential (VEPs)

Indexed keywords

ADOLESCENT; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL ARTICLE; COLOR BLINDNESS; COLOR VISION DEFECT; COLOR VISION TEST; CONTRAST; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; ELECTRORETINOGRAPHY; EVOKED VISUAL RESPONSE; FEMALE; FOURIER ANALYSIS; HUMAN; MALE; NYSTAGMUS; PHOTORECEPTOR; RETINA DYSTROPHY; RETINA MACULA LUTEA; SIGNAL NOISE RATIO; STIMULUS; VISUAL STIMULATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; CONES (RETINA); ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; RETINAL DISEASES; SYNDROME;

EID: 0344520377     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022909328103     Document Type: Article

References (60)

1. Krill AE, Deutman AF. Dominant macular degenerations: The cone dystrophies. Am J Ophthalmol 1972; 73: 352-369.
2. Goodman G, Ripps H, Siegel IM. Cone dysfunction syndromes. Arch Ophthalmol 1963; 70: 214-231.
3. Berson EL, Gouras P, Gunkel RD. Progressive cone degeneration, dominantly inherited. Arch Ophthalmol 1968; 80: 77-83.
4. Ripps H, Noble KG, Greenstein VC, Siegel IM, Carr RE. Progressive cone dystrophy. Ophthalmology. 1987; 94: 1401-1409.
5. Reichel E, Bruce AM, Sandberg MA, Berson EL. An electroretinographic and molecular genetic study of X-linked cone degeneration. Am J Ophthalmol 1989; 108: 540-547.
6. Keunen JE, Van Everdingen JA, Went LN, Oosterhuis JA, Van Norren D. Color matching and foveal densitometry in patients and carriers of an X-linked progressive cone dystrophy. Arch Ophthalmol 1990; 108: 1713-1719.
7. Nathans J, Maumenee IH, Zrenner E, et al. Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet 1993; 53: 987-1000.
8. Kohl S, Marx T, Giddings I, et al. Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cgMP-gated cation channel. Nat Genet 1998; 19: 257-259.
9. Kohl S, Baumann B, Broghammer M, et al. Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cgMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet 2000; 9: 2107-2116.
10. Sundin OH, Yang JM, Li Y, et al. Genetic basis of total colourblindness among the Pingelapese islanders. Nat Genet 2000; 25: 289-293.
11. Fishman GA, Stone EM, Alexander KR, Gilbert LD, Derlacki DJ, Butler NS. Serine-27-phenylalanine mutation within the peripherin/RDS gene in a family with cone dystrophy. Arch Ophthalmology 1997; 104: 299-306.
12. Payne AM, Downes SM, Bessant DA, et al. A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21. Hum Mol Genet 1998; 7: 273-277.
13. Sokal I, Li N, Surgucheva I, et al. GCAP1 (Y99C) mutant is constitutively active in autosomal dominant cone dystrophy. Mol Cell 1998; 2: 129-133.
14. Jacobson SG, Apathy PP, Parel J-M. Rod and cone perimetry: Computerized testing and analysis. In: Heckenlively J, Arden GB, eds. Principles and Practice of Clinical Vision Testing. St. Louis, MO: Mosby-Year Book; 1991: 475-482.
15. Jacobson SG, Cideciyan AV, Huang Y, et al. Retinal degenerations with truncation mutations in the cone-rod homeobox (CRX) gene. Invest Ophthalmol Vis Sci 1998; 39: 2417-2426.
16. Kremers J, Usui T, Scholl HP, Sharpe LT. Cone signal contributions to electroretinograms in dichromats and trichromats. Invest Ophthalmol Vis Sci 1999; 40: 920-930.
17. Kretschmann U, Seeliger M, Ruether K, Usui T, Zrenner E. Spatial cone activity distribution in diseases of the posterior pole determined by multifocal electroretinography. Vision Res 1998; 38: 3817-3828.
18. Kretschmann U, Stilling R, Ruther K, Zrenner E. Familial macular cone dystrophy: Diagnostic value of multifocal ERG and two-color threshold perimetry. Graefes Arch Clin Exp Ophthalmol 1999; 237: 429-432.
19. Sakaue H, Katsumi O, Mehta M, Hirose T. Simultaneous pattern reversal ERG and VER recordings. Invest Ophthalmol Vis Sci 1990; 31: 506-511.
20. Rabin J, Switkes E, Crognale M, et al. Visual evoked potentials in three-dimensional color space: Correlates of spatio-chromatic processing. Vision Res 1994; 34: 2657-2626.
21. Jacobson DM, Thompson HS, Bartley JA. X-linked progressive cone dystrophy. Clinical characteristics of affected males and female carriers. Ophthalmology 1989; 99: 885-895.
22. Sanberg MA, Berson EL, Ariel M. Visually evoked response testing with a stimulator- ophthalmoscope. Macular scars, hereditary macular degenerations, and retinitis pigmentosa. Arch Ophthalmol 1977; 95: 1805-1808.
23. Bodis-Wollner I, Feldman RG, Guillory SL, Mylin L. Delayed visual evoked potentials are independent of pattern orientation in macular disease. Electroencephalogr Clin Neurophysiol 1987; 68: 172-179.
24. Lennerstrand G. Delayed visual evoked cortical potential in retinal disease. Acta Ophthalmol 1982; 60: 497-504.
25. Bass SJ, Sherman J, Bodis-Wollner I, Nath S. Visual evoked potentials in macular disease. Invest Ophthalmol Vis Sci 1995; 35: 1385-1392.
26. Celesia GG, Kaufman D. Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases. Invest Ophthalmol Vis Sci 1985; 26: 726-735
27. Kriss A, Russell-Eggitt I. Electrophysiological assessment of visual pathway function in infants. Eye 1992; 6: 145-153.
28. Lavy T, Harris CM, Shawkat F, Thompson D, Taylor D, Kriss A. Electrophysiological and eye-movement abnormalities in children with the Bardet-Biedl syndrome. J Pediatr Ophthalmol Strabismus 1995; 32: 364-367.
29. Murray I.J, Parry NRA, Carden D, Kulikowski JJ. Human visual evoked potentials to chromatic and achromatic gratings. Clin Vis Sci 1987; 1: 231-244.
30. Crognale MA, Kelly JP, Weiss AH, Teller DY. Development of the spatio-chromatic visual evoked potential (VEP): A longitudinal study. Vision Res 1998; 38: 3283-3292.
31. Porciatti V, Sartucci F. Normative data for onset VEPs to redgreen and blue-yellow chromatic contrast. Clin Neurophysiol. 1999; 110: 772-781.
32. Crognale MA, Switkes E, Rabin J, et al. Application of the spatiochromatic visual evoked potential to detection of congenital and acquired color-vision deficiencies. J Opt Soc Am A 1993; 10: 1818-1825.
33. Crognale MA, Rabin J, Switkes E, Adams AJ. Selective loss of S-pathway sensitivity in central serous choroidopathy revealed by spatio-chromatic visual evoked cortical potentials (VECP). In Drum B, ed. Colour Vision Deficiences XI. Dordrecht: Kluwer Academic Publishers; 1992: 239-249.
34. Crognale MA, Switkes E, Rabin J, et al. Objective assessment of short wavelength sensitive (SWS) mechanisms with the spatio-chromatic VEP: X-linked achromatopsia and transient tritanopia. In: Drum B, ed. Colour Vision Deficiences XII. Dordrecht: Kluwer Academic Publishers Dordrecht; 1995: 407-413.
35. Regan D. Evoked potentials specific to spatial patterns of luminance and colour. Vision Res 1973; 13: 2381-2402.
36. Regan D, Spekreijse H. Evoked potential indications of colour blindness. Vision Res 1974; 14: 89-95.
37. Berninger TA, Arden GB, Hogg CR, Frumkes T. Separable evoked retinal and cortical potentials from each major visual pathway: Preliminary results. Br J Ophthalmol 198; 73: 502-511.
38. Marmor MF, Arden GB, Nilssoin SEG, Zrenner E. Standard for clinical electroretinography. Arch Ophthalmol 1989; 107: 816-819.
39. Harding GFA, Odom, JV, Spileers W, Spekreijse H. Standard for visual evoked potentials 1995. Vision Res 1996; 36: 3567-3572.
40. Beiber ML, Volbrecht VJ, Werner JS. Spectral efficiency measured by heterochromatic flicker photometry is similar in human infants and adults. Vision Res 1995; 35: 1385-1392.
41. Kelly JP, Chang S. Development of chromatic and luminance detection contours using the sweep VEP. Vision Res 2000; 40: 1887-1905.
42. Cole GR, Hine T. Computation of cone contrasts for color vision research. Behav Res Methods Instrum Comput 1992; 24: 22-27.
43. Banks M S, Bennett PJ. Optical and photoreceptor immaturities limit the spatial and chromatic vision of human infants. J Opt Soc Am 1988; 5: 2059-2079.
44. Kelly JP, Borchert K, Teller DY. The development of chromatic and achromatic contrast sensitivity in infancy as tested with the sweep VEP. Vision Res 1997; 37: 2057-2072.
45. Victor JD, Mast J. A A new statistic for steady-state evoked potentials. Electroencephalogr Clin Neurophysiol 1991; 78: 378-388.
46. Van Der Tweel H, Estevez O. Analytical techniques. In: Heckenlively J, Arden GB, eds. St. Louis, MO: Mosby-Year Book, 1991: 231-253.
47. Zemon V, Hartmann, EE, Gordon J, Prunte-Glowazki A. An electrophysiological technique for assessment of the development of spatial vision. Optom Vis Sci 1997; 74: 708-716.
48. Berson EL, Sandberg MA, Rosner B, et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol 1985; 99: 240-251.
49. Berson EL, Gouras P, Hoff M. Temporal aspects of the electroretinogram. Arch Ophthalmol 1969; 81; 207-214.
50. Berson EL, Sandberg MA, Rosner B, Sullivan PL. Color plates to help identify patients with blue cone monochromatism. Am J Ophthalmol 1983; 95L: 741-747.
51. Reichel E, Bruce AM, Sandberg MA, et al. An electroretinographic and molecular genetic study of X-linked cone degeneration. Am J Ophthalmol 1989; 108: 540-547.
52. Apkarian P. Visual evoked potential assessment of visual function in pediatric neuroophthalmology. Principles and Practice of Ophthalmology, Basic Sciences. 1994: 622-647.
53. Rosenberg ML, Jabbari B. Nystagmus and visual evoked potentials. Neuro-Ophthalmology 1987; 7: 133-138.
54. Arlt A, Zangemeister WH. Influence of slow eye movements and nystagmus on pattern induced visual evoked potentials. Neuro-Ophthalmology 1990; 10: 241-251.
55. Haegerstrom-Portnoy G, Schneck ME, Verdon WA, Hewlett SE. Clinical vision characteristics of the congenital achromatopsias. II. Color vision. Optom Vis Sci 1996; 73: 457-465.
56. Krill AE, Deutman AF, Fishman M. The cone degenerations. Doc Ophthalmol 1973; 35: 1-80.
57. Sadowski B, Zrenner E. Cone and rod function in cone degenerations. Vision Res 1997; 37: 2303-2314.
58. Switkes E, Crognale MA, Rabin J, Schneck ME, Adams AJ. Reply to 'Specificity and selectivity of chromatic visual evoked potentials.' Vision Res 1996; 36: 3403-3405.
59. Klingaman RL. A rod monochromat's pattern VECP at high and low background levels: Spatial tuning of colour mechanisms and rods compared. Ophthalmic Physiol Opt 1984; 4: 139-142.
60. Benedek G, Janaky M, Adamkovich N, Rubicsek G, Sary G. Scotopic pattern-reversal visual evoked potentials. Clin Vis Sci 1993; 8: 47-54.